| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.5M | -2.7% |
| Cost of Revenue | $8.2M | -2.6% |
| Gross Profit | $1.3M | -3.0% |
| R&D Expense | $48K | -13.6% |
| SG&A Expense | $2.0M | -55.2% |
| Operating Income | -$1.6M | +39.3% |
| Pre-tax Income | -$1.6M | +38.8% |
| Income Tax | -$3K | +83.8% |
| Net Income | -$1.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $1.4M | +22.0% |
| Current Assets | $7.4M | -7.7% |
| Total Assets | $10.4M | -8.5% |
| Current Liabilities | $2.0M | +19.6% |
| Total Liabilities | $2.1M | +21.2% |
| Stockholders' Equity | $8.3M | -13.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | -71.7% |
| Capital Expenditures | $227K | — |
| Investing Cash Flow | $418K | +209.3% |
| Financing Cash Flow | $145K | -97.5% |
| Free Cash Flow | -$2.5M | -89.1% |
| +39.2% |
| EPS (Diluted) | -$0.09 | +45.8% |